Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 6/20 | 0.66 |
| ▸ | PRMT6 | Q96LA8 | 6/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL11102143 | 0.98 | CARM1 (0.64) | CARM1PRMT6CYP2C19CYP2C9MEN1 | |
| SCHEMBL24649296 | 0.86 | CARM1 (0.58) | CARM1PRMT6MEN1KMT2ARAB9A | |
| SCHEMBL4677340 | 0.86 | MEN1 (0.60) | CARM1PRMT6CYP2C19CYP2C9MEN1 | |
| SCHEMBL4677304 | 0.86 | MEN1 (0.60) | CARM1PRMT6CYP2C19CYP2C9MEN1 | |
| SCHEMBL8310068 | 0.86 | MEN1 (0.63) | CARM1PRMT6CYP2C19CYP2C9MEN1 | |
| SCHEMBL11294240 | 0.84 | MEN1 (0.61) | CARM1PRMT6CYP2C19CYP2C9MEN1 | |
| SCHEMBL9200501 | 0.84 | CARM1 (0.56) | CARM1PRMT6 | |
| SCHEMBL9199910 | 0.84 | CARM1 (0.56) | CARM1PRMT6 | |
| SCHEMBL24648968 | 0.84 | CARM1 (0.56) | CARM1PRMT6MEN1KMT2ALMNA | |
| SCHEMBL30956341 | 0.84 | MEN1 (0.59) | CARM1PRMT6MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919844-B2 | Antibacterials and/or modulators of biofilm formation and methods of using the same | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2021-02-16 | — | — | US | disclosed |
| US-20180215704-A1 | ANTIBACTERIALS AND/OR MODULATORS OF BIOFILM FORMATION AND METHODS OF USING THE SAME | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919844-B2 | Antibacterials and/or modulators of biofilm formation and methods of using the same | NRDC, FIBP, BMP2 | CARM1 4368/4885PRMT6 2729/4885CYP2C19 1463/4885 |
| US-20180215704-A1 | ANTIBACTERIALS AND/OR MODULATORS OF BIOFILM FORMATION AND METHODS OF USING THE SAME | NRDC, FIBP, BMP2 | CARM1 4368/4885PRMT6 2729/4885CYP2C19 1463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.